Navigation Links
M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market

LONDON, April 12, 2012 /PRNewswire/ --

- - Finger Vein Identity Management Solution a Perfect Fit for the M2SYS Biometrics Product Portfolio - -

Hitachi Europe Ltd. and M2SYS Technology today announced that they have entered into a strategic partnership making M2SYS Hitachi's primary Value Added Reseller in North America for the H1 Biometric Finger Vein scanner.

Biometric Finger Vein identity management scanning technology was developed by Hitachi to provide safer and more secure authentication for access control and other identification purposes. Using near infrared light to detect and capture the vein pattern inside a finger, the H1 Finger Vein scanner is a unique solution for cost-effective identity management. Finger Vein biometric identity management technology is safe because vein patterns are internal to the body so forge them is virtually impossible, effectually making counterfeiting improbable and providing a high level of security.

Michael Trader, president of M2SYS said: "M2SYS has made a name by providing specialty enterprise-ready biometric software and hardware solutions and Hitachi's H1 Finger Vein scanners are a perfect fit for us. By adding this to our portfolio of biometric solutions, we will be able to better customize our offerings to the specific needs of our customers across the globe."

Ravi Ahluwalia, Deputy General Manager, Head of Identity Management Group, Information Systems Group of Hitachi Europe said: "We are very pleased to be partnering with a renowned company like M2SYS. Their range of specialized products in the biometrics area is a perfect fit. This strategic partnership provides a key benefit to M2SYS's customers by giving them access to proven, easy-to-use identity management technology."

About Hitachi Europe Ltd.

Hitachi Europe Ltd., is a wholly owned subsidiary of Hitachi, Ltd., Japan. Headquartered in Maidenhead, UK, it has operations in 12 countries across Europe, the Middle East and Africa and employs approximately 625 people.

Hitachi Europe comprises of eight business areas: rail systems; power and industrial systems; information systems; digital media and consumer products; industrial components and equipment; air conditioning and refrigeration systems; manufacturing systems; and procurement and sourcing. Hitachi Europe also has three Research and Development laboratories and a design centre. For more information about the company, please visit


Hitachi, Ltd., (NYSE: HIT / TSE: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 360,000 employees worldwide. Fiscal 2010 (ended March 31, 2011) consolidated revenues totaled 9,315 billion yen ($112.2 billion). Hitachi will focus more than ever on the Social Innovation Business, which includes information and telecommunication systems, power systems, environmental, industrial and transportation systems, and social and urban systems, as well as the sophisticated materials and key devices that support them. For more information on Hitachi, please visit the company's website at

About M2SYS Technology

M2SYS Technology,, provides technology that makes biometric software affordable, simple to integrate and inexpensive to support enabling customers to easily utilize the right form of biometric technology for their needs.  The M2SYS Corporate Blog can be found at

SOURCE Hitachi Europe Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform(TM) That Offers Unparalleled Flexibility to End-Users
2. Frost & Sullivan Recognizes M2SYS for its Path-Breaking Hybrid Biometric Platform™ That Offers Unparalleled Flexibility to End-Users
3. Qqest Teams Up With M2SYS to Add Biometric Technology at the Desktop to TimeForce Time and Attendance System
4. Qqest Teams Up With M2SYS to Add Biometric Technology at the Desktop to TimeForce Time and Attendance System
5. M2SYS Biometric Software Solution Selected By GHG Corporation
6. M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers
7. ACS Technologies(TM) Selects M2SYS for Innovative Biometric Software
8. M2SYS Technology to Offer Desktop Biometric Technology to Kronos Customers
9. InvoTech Selects M2SYS Technology for Leading-Edge Fingerprint Software Solution
10. New technology tracks sparrow migration for first time from California to Alaska
11. Powerful sequencing technology decodes DNA folding pattern
Post Your Comments:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 Houston Methodist Willowbrook ... Cy-Fair Sports Association to serve as their official ... Houston Methodist Willowbrook will provide sponsorship support, athletic ... with association coaches, volunteers, athletes and families. ... Cy-Fair Sports Association and to bring Houston Methodist ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... the Pennsylvania Convention Center and will showcase its product’s latest features from June ... be presenting a scientific poster on Disrupting Clinical Trials in The Cloud during ...
Breaking Biology Technology: